Accessibility Menu
Turn Therapeutics Stock Quote

Turn Therapeutics (NASDAQ: TTRX)

$3.27
(20.7%)
+0.56
Price as of November 21, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$3.27
Daily Change
(20.7%) +$0.56
Day's Range
$2.60 - $3.36
Previous Close
$3.27
Open
$2.71
Beta
1.83
Volume
146,717
Average Volume
784,377
Market Cap
79.8M
Market Cap / Employee
$2.71M
52wk Range
$2.57 - $26.50
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
-$0.13
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Turn Therapeutics Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
TTRXN/AN/AN/A-61%
S&P+10.51%+83.8%+12.94%-3%

Turn Therapeutics Company Info

Global Health Solutions Inc is an American company that works with partners to eliminate diseases that have plagued humanity for centuries and protect the health of populations by helping countries build strong health systems. The private company is located in the US. The company brings together key stakeholders around the world with a common goal to stop diseases and strengthen health systems through powerful partnerships. The company consists of programs and focus areas that cover a range of health issues including neglected tropical diseases, infectious diseases, vaccines, field epidemiology, public health informatics, health workforce development, and health ethics. The company's end goal is to eliminate diseases and protect the health of populations.

News & Analysis

No results found

No news articles found for Turn Therapeutics.

Financial Health

General

Q3 2025YOY Change
Revenue$0.00M0.0%
Gross Profit-$0.01M0.0%
Net Income-$1.90M0.0%
EBITDA-$1.90M0.0%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$3.11M0.0%
Inventory00.0%

Liabilities

Q3 2025YOY Change
Long Term Debt$0.05M0.0%
Short Term Debt$0.04M0.0%

Ratios

No data available

No data available for this period.

Cash Flow

Q3 2025YOY Change
Free Cash Flow-$0.59M0.0%
Operating Free Cash Flow-$0.59M0.0%

Valuation

MetricQ2 2025Q3 2025YoY Change
Total Debt$0.10M$0.09M-

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.